Photo from wikipedia
While the use of convalescent plasma (CP) in the ongoing COVID‐19 pandemic has been inconsistent, CP has the potential to reduce excess morbidity and mortality in future pandemics. Given constraints… Click to show full abstract
While the use of convalescent plasma (CP) in the ongoing COVID‐19 pandemic has been inconsistent, CP has the potential to reduce excess morbidity and mortality in future pandemics. Given constraints on CP supply, decisions surrounding the allocation of CP must be made.
Keywords:
allocation strategies;
mortality;
reduce excess;
convalescent plasma;
comparison allocation
Journal Title: Transfusion
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!